3i Group and L’Oréal stock-picks boost Fidelity European Trust in April

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for April 2025.

Portfolio Manager Commentary 

Continental European equities declined in April, reflecting ongoing volatility across global markets, while the introduction of tariff uncertainty has reduced confidence in future growth.   

The Trust underperformed the index during the month, primarily due to weak stock picking in the energy, industrials, and health care sectors, while impact of gearing had a small positive impact. TotalEnergies traded lower in line with the broader energy sector, which was pressured by falling commodity prices and concerns over slowing global growth amid rising trade tensions. Despite in-line Q1 results across all divisions, weaker-than expected cash flow due to a sharp rise in working capital, hybrid repayments, and FX effects disappointed investors. An additional drag came from the Trust’s exposure to private equity business Partners Group. In contrast, 3i Group was a top contributor, driven by its stake in discount retailer Action. Action sells cheap products from China and SouthEast Asia into Europe and is therefore positioned as a tariff beneficiary. Shares in L’Oréal rose after the company reported an increase in Q1 sales.   

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. On a rolling 12-month basis, the Trust recorded NAV and share price returns of 1.5% and 2.2% respectively, compared to FTSE World Europe (ex UK) Index that returned 7.2%. 

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

European defence stocks climb on German procurement momentum

Germany’s military procurement plans have kicked defence stocks into motion, giving investors a clearer signal on where the capital is headed.

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

Search

Search